Plasma phospholipid transfer protein activity is inversely associated with betaine in diabetic and non-diabetic subjects.
Plasma phospholipid transfer protein activity is inversely associated with betaine in diabetic and non-diabetic subjects.
复制标题
DOI:
10.1186/s12944-016-0313-5
复制
发表时间:
2016-08-31
影响因子:
4.5
通讯作者:
Connelly MA
中科院分区:
文献类型:
--
作者:
Dullaart RP;Garcia E;Jeyarajah E;Gruppen EG;Connelly MA
The choline metabolite, betaine, plays a role in lipid metabolism, and may predict the development of cardiovascular disease and type 2 diabetes mellitus (T2DM). Phospholipid transfer protein (PLTP) and lecithin:cholesterol acyltransferase (LCAT) require phosphatidylcholine as substrate, raising the possibility that there is an intricate relationship of these protein factors with choline metabolism. Here we determined the relationships of PLTP and LCAT activity with betaine in subjects with and without T2DM. Plasma betaine (nuclear magnetic resonance spectroscopy), PLTP activity (liposome-vesicle HDL system), LCAT activity (exogenous substrate assay) and (apo)lipoproteins were measured in 65 type 2 diabetic (T2DM) and in 55 non-diabetic subjects. PLTP and LCAT activity were elevated in T2DM (p < 0.05), whereas the difference in betaine was not significant. In age-, sex- and diabetes status-controlled correlation analysis, betaine was inversely correlated with triglycerides and positively with HDL cholesterol (p < 0.05 to 0.01). PLTP and LCAT activity were positively correlated with triglycerides and inversely with HDL cholesterol (p < 0.05 to 0.001). PLTP (r = −0.245, p = 0.006) and LCAT activity (r = −0.195, p = 0.035) were correlated inversely with betaine. The inverse association of PLTP activity with betaine remained significant after additional adjustment for body mass index and lipoprotein variables (β = −0.179, p = 0.034), whereas its association with LCAT activity lost significance (β = −0.056, p = 0.44). Betaine may influence lipoprotein metabolism via an effect on PLTP activity.
登录
查看更多内容
影响因子:
3.7
作者:
Lever M;George PM;Slow S;Bellamy D;Young JM;Ho M;McEntyre CJ;Elmslie JL;Atkinson W;Molyneux SL;Troughton RW;Frampton CM;Richards AM;Chambers ST
通讯作者:
Chambers ST
影响因子:
11.1
作者:
Dullaart, R. P. F.;Vergeer, M.;Dallinga-Thie, G. M.
通讯作者:
Dallinga-Thie, G. M.
影响因子:
7.7
作者:
Walford GA;Ma Y;Clish C;Florez JC;Wang TJ;Gerszten RE;Diabetes Prevention Program Research Group
通讯作者:
Diabetes Prevention Program Research Group
影响因子:
39.3
作者:
Wang, Zeneng;Tang, W. H. Wilson;Hazen, Stanley L.
通讯作者:
Hazen, Stanley L.
影响因子:
3.7
作者:
Lever M;George PM;Atkinson W;Molyneux SL;Elmslie JL;Slow S;Richards AM;Chambers ST
通讯作者:
Chambers ST